These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 31289068)

  • 1. RAIN study: a protocol for a randomised controlled trial evaluating efficacy, safety and cost-effectiveness of intravenous-to-oral antibiotic switch therapy in neonates with a probable bacterial infection.
    Keij FM; Kornelisse RF; Hartwig NG; Mauff K; Poley MJ; Allegaert K; Reiss IKM; Tramper-Stranders GA
    BMJ Open; 2019 Jul; 9(7):e026688. PubMed ID: 31289068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of switching from intravenous to oral antibiotics (amoxicillin-clavulanic acid) versus a full course of intravenous antibiotics in neonates with probable bacterial infection (RAIN): a multicentre, randomised, open-label, non-inferiority trial.
    Keij FM; Kornelisse RF; Hartwig NG; van der Sluijs-Bens J; van Beek RHT; van Driel A; van Rooij LGM; van Dalen-Vink I; Driessen GJA; Kenter S; von Lindern JS; Eijkemans M; Stam-Stigter GM; Qi H; van den Berg MM; Baartmans MGA; van der Meer-Kappelle LH; Meijssen CB; Norbruis OF; Heidema J; van Rossem MC; den Butter PCP; Allegaert K; Reiss IKM; Tramper-Stranders GA
    Lancet Child Adolesc Health; 2022 Nov; 6(11):799-809. PubMed ID: 36088952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early switch from intravenous to oral antibiotic therapy in patients with cancer who have low-risk neutropenic sepsis (the EASI-SWITCH trial): study protocol for a randomised controlled trial.
    Forde C; McMullan R; Clarke M; Wilson RH; Plummer R; Grayson M; McDowell C; Agus A; Doran A; McAuley DF; Thomas AL; Barnes RA; Adams R; Chau I; Coyle V
    Trials; 2020 May; 21(1):431. PubMed ID: 32460818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral versus intravenous antibiotic treatment for bone and joint infections (OVIVA): study protocol for a randomised controlled trial.
    Li HK; Scarborough M; Zambellas R; Cooper C; Rombach I; Walker AS; Lipsky BA; Briggs A; Seaton A; Atkins B; Woodhouse A; Berendt A; Byren I; Angus B; Pandit H; Stubbs D; McNally M; Thwaites G; Bejon P
    Trials; 2015 Dec; 16():583. PubMed ID: 26690812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral switch versus standard intravenous antibiotic therapy in left-sided endocarditis due to susceptible staphylococci, streptococci or enterococci (RODEO): a protocol for two open-label randomised controlled trials.
    Lemaignen A; Bernard L; Tattevin P; Bru JP; Duval X; Hoen B; Brunet-Houdard S; Mainardi JL; Caille A;
    BMJ Open; 2020 Jul; 10(7):e033540. PubMed ID: 32665381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Switch from intravenous-to-oral antibiotics in neonatal probable and proven early-onset infection: a prospective population-based real-life multicentre cohort study.
    Malchau Carlsen EL; Dungu KHS; Lewis A; Vissing NH; Aunsholt L; Trautner S; Stanchev H; Dayani GK; Pedersen AL; Bjerager M; De Salas M; Vestergaard K; Pedersen P; Frimodt-Møller N; Greisen G; Hansen BM; Nygaard U
    Arch Dis Child Fetal Neonatal Ed; 2023 Dec; 109(1):34-40. PubMed ID: 37369601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of anti-inflammatory or antibiotic treatment in patients with non-complicated acute bronchitis and discoloured sputum: randomised placebo controlled trial.
    Llor C; Moragas A; Bayona C; Morros R; Pera H; Plana-Ripoll O; Cots JM; Miravitlles M
    BMJ; 2013 Oct; 347():f5762. PubMed ID: 24097128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial non-operative management of uncomplicated appendicitis in children: a protocol for a multicentre randomised controlled trial (APAC trial).
    Knaapen M; van der Lee JH; Bakx R; The SL; van Heurn EWE; Heij HA; Gorter RR;
    BMJ Open; 2017 Nov; 7(11):e018145. PubMed ID: 29146647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of early switch from intravenous to oral antibiotics in severe community acquired pneumonia: multicentre randomised trial.
    Oosterheert JJ; Bonten MJ; Schneider MM; Buskens E; Lammers JW; Hustinx WM; Kramer MH; Prins JM; Slee PH; Kaasjager K; Hoepelman AI
    BMJ; 2006 Dec; 333(7580):1193. PubMed ID: 17090560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of pharmacokinetically enhanced amoxicillin-clavulanate at 2,000/125 milligrams twice daily for 5 days versus amoxicillin-clavulanate at 875/125 milligrams twice daily for 7 days in the treatment of acute exacerbations of chronic bronchitis.
    Sethi S; Breton J; Wynne B
    Antimicrob Agents Chemother; 2005 Jan; 49(1):153-60. PubMed ID: 15616290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early oral switch therapy in low-risk Staphylococcus aureus bloodstream infection (SABATO): study protocol for a randomized controlled trial.
    Kaasch AJ; Fätkenheuer G; Prinz-Langenohl R; Paulus U; Hellmich M; Weiß V; Jung N; Rieg S; Kern WV; Seifert H;
    Trials; 2015 Oct; 16():450. PubMed ID: 26452342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral bioavailability and pharmacokinetic profile of the amoxicillin-clavulanic acid combination after intravenous and oral gavage administration in broiler chickens.
    Jerzsele A; Nagy G; Lehel J; Semjen G
    J Vet Pharmacol Ther; 2009 Oct; 32(5):506-9. PubMed ID: 19754920
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy of short-term intravenous antibiotic in neonates with urinary tract infection.
    Magín EC; García-García JJ; Sert SZ; Giralt AG; Cubells CL
    Pediatr Emerg Care; 2007 Feb; 23(2):83-6. PubMed ID: 17351406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fosfomycin versus meropenem in bacteraemic urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli (FOREST): study protocol for an investigator-driven randomised controlled trial.
    Rosso-Fernández C; Sojo-Dorado J; Barriga A; Lavín-Alconero L; Palacios Z; López-Hernández I; Merino V; Camean M; Pascual A; Rodríguez-Baño J;
    BMJ Open; 2015 Mar; 5(3):e007363. PubMed ID: 25829373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral bioavailability and pharmacokinetic profile of the amoxicillin-clavulanic acid combination after intravenous and oral administration in Turkeys.
    Jerzsele A; Nagy G; Semjen G
    J Vet Pharmacol Ther; 2011 Apr; 34(2):202-5. PubMed ID: 21395615
    [No Abstract]   [Full Text] [Related]  

  • 16. Early use of Antibiotics for at Risk CHildren with InfluEnza (ARCHIE): protocol for a double-blind, randomised, placebo-controlled trial.
    Wang K; Carver T; Tonner S; Semple MG; Hay AD; Moore M; Little P; Butler C; Farmer A; Perera R; Yu LM; Mallett S; Wolstenholme J; Harnden A
    BMJ Open; 2018 May; 8(5):e021144. PubMed ID: 29769256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis of amoxicillin-clavulanic acid (Xiclav) efficacy and the possibility of early switch from parenteral to oral therapy in the treatment of infections].
    Ahmetagić S; Jusufović E; Cengić D; Koluder N; Bajramović N; Calkić L; Hadzić E; Salaka U; Sijercić M
    Med Arh; 2003; 57(5-6):263-6. PubMed ID: 15022575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pivmecillinam with Amoxicillin/Clavulanic acid as step down oral therapy in febrile Urinary Tract Infections caused by ESBL-producing Enterobacterales (PACUTI).
    Tverring J; Månsson E; Andrews V; Ljungquist O
    Trials; 2023 Sep; 24(1):568. PubMed ID: 37660037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early switch of intravenous to oral antibiotic therapy in clinically well neonates with a probable bacterial infection is as effective as a full course of intravenous antibiotics therapy.
    Abdalhady M; Harrison CM
    Arch Dis Child Educ Pract Ed; 2023 Aug; 108(4):290-291. PubMed ID: 37197897
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of tebipenem pivoxil hydrobromide on the normal gut microbiota of a healthy adult population in Sweden: a randomised controlled trial.
    Sewunet T; Razavi M; Rosenborg S; Camporeale A; Nowak M; Melnick D; Gasink LB; Eckburg PB; Critchley IA; Nord CE; Giske CG
    Lancet Microbe; 2024 Apr; 5(4):e355-e365. PubMed ID: 38432233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.